New approach to stem cell transplantation may overcome immune rejection

Cell and organ transplants can be lifesaving, but patients often encounter long waiting lists due to the shortage of suitable donors.

Gedeon Richter becomes strategic investor of Formycon via equity investment – Biotech Investments

EQS-News: Formycon AG / Key word(s): Capital Increase Gedeon Richter becomes strategic investor of Formycon via equity investment 29.01.2024 / 22:15 CET/CEST The issuer is

January 30, 2024

Thermo Fisher is ready to expand its viral vector production site in Massachusetts once there’s ‘demand for it’

PLAINVILLE, Mass. — Just a year after opening its $180 million viral vector manufacturing site in Massachusetts, Thermo Fisher already has expansion on its mind.

September 20, 2023

After promising early data, gene therapy trial for Huntington’s takes puzzling turn

Last year, after a string of high-profile trial failures, the Huntington’s disease community got positive news in the form of very early data from an

June 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.